Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc.

World Rank (Jan-05-2024)
17,121
Market Cap (Jan-05-2024)
0.232 Billion USD
World Rank (Jul-30-2023)
20,456
Market Cap (Jul-30-2023)
0.126 Billion USD
World Rank (Jan-07-2022)
10,597
Market Cap (Jan-07-2022)
0.812 Billion USD
World Rank (Jan-01-2021)
5,300
Market Cap (Jan-01-2021)
2.105 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
PRAX
Market Cap (Mar-08-2026)
8.65
Employee Count
139
Employee Count as of Date
As on 2021
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-167 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
292 Million USD
Total Liabilities in USD
41 Million USD
Total Equity in USD
250 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Healthcare
Biotechnology
Company Website
PRAXIS PRECISION MEDICINES, INC.
Yahoo
Yahoo @ Nasdaq
Company Profile
Praxis is a Clinical Stage Biopharmaceutical company translating genetic insights into the development of therapies for patients affected by central nervous system (“CNS”) disorders characterized by neuronal imbalance. The company annual net income is 35.5 million USD. The headquarters is in USA.
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share